ABVX Stock Analysis: Buy, Sell, or Hold?

ABVX - Abivax SA American Depositary Shares

Pharmaceutical Preparations
$109.87
-2.03 (-1.81%) β–Ό
5d: -1.4%
30d: +7.22%
90d: -7.59%
HOLD
MODERATE Confidence
Analysis Updated: Apr 28, 2026 12:00 AM ET
Earnings: Jun 01, 2026

Get Alerted When ABVX Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

πŸ’‘
Bottom Line:
πŸ“Š HOLD: ABVX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
See Forward Earnings Fair Value & Price Prediction β†’

In-depth Analysis How we analyze

Valuation Analysis: ABVX is currently trading at $109.87, which is considered fair relative to its 30-day fair value range of $109.98 to $122.54.

Technical Outlook: Technically, ABVX is in a strong uptrend. The price is currently testing key support at $109.77. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: ABVX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $155.20 (+41.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $109.98 - $122.54
Company Quality Score 53/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 50.0%

All Signals

  • NEUTRAL: Price in fair range
  • BEARISH: Weak technical setup (25/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 41.3% below Wall St target ($155.20)

Trading Range Analysis

30-Day Trading Range $109.98 - $122.54
Current vs Trading Range FAIR

Support & Resistance Levels

Support Level $109.77
Resistance Level $126.80
Current Trend Strong Uptrend
Technical data as of Apr 28, 2026

Fundamental Context

Forward P/E (Next Year Est.) -38.55
Wall Street Target $155.20 (+41.3%)
Revenue Growth (YoY) -55.4%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: April 29, 2026 8:46 AM ET
Data refreshes hourly during market hours. Next update: 9:46 AM
πŸ”₯ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
LEGN
Legend BiotechΒ Corp
STRONG BUY
22 analysts
$57 59 HOLD
VRTX
Vertex Pharmaceuticals I…
BUY
34 analysts
$548 59 HOLD
RARE
Ultragenyx
STRONG BUY
20 analysts
$53 65 BUY
REGN
Regeneron Pharmaceutical…
STRONG BUY
25 analysts
$878 58 HOLD
XENE
Xenon Pharmaceuticals Inc
STRONG BUY
19 analysts
$79 56 HOLD

More Analysis for ABVX

ABVX Technical Chart ABVX Price Prediction ABVX Earnings Date ABVX Investment Advisor ABVX Fair Price Analyzer ABVX Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals